Publication | Closed Access

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA

UrologyEngineeringOncologic ImagingMedical ImagingMedicineBiomedical ImagingElevated PsaDiffusion-weighted ImagingMri-guided Radiation TherapyProstatic DiseaseDynamic Contrast-enhanced ImagingOncologyNuclear MedicineMolecular ImagingMagnetic Resonance ImagingRadiology